FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
3,713 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Aurolife Pharma LLC | ANDA | 13107-015 | 13107-0015-01 | — |
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Alembic Labs LLC | ANDA | 15955-305 | 15955-0305-01 | — |
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Alembic Labs LLC | ANDA | 15955-318 | 15955-0318-01 | — |
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | NDA authorized generic | 16571-743 | 16571-0743-03 |
| — |
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Rising Pharma Holdings, Inc. | NDA authorized generic | 16571-744 | 16571-0744-0316571-0744-09 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc., | ANDA | 16729-471 | 16729-0471-08 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc., | ANDA | 16729-472 | 16729-0472-08 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc., | ANDA | 16729-473 | 16729-0473-03 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Accord Healthcare, Inc., | ANDA | 16729-474 | 16729-0474-03 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Atlantic Biologicals Corp. | ANDA | 17856-1016 | 17856-1016-0117856-1016-02 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-606 | 23155-0606-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | 23155-607 | 23155-0607-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Sagent Pharmaceuticals | ANDA | 25021-796 | 25021-0796-0125021-0796-0225021-0796-05 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-016 | 31722-0016-47 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Solco Healthcare US, LLC | ANDA | 43547-543 | 43547-0543-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .4 mg/2mL | InjectionIntramuscular, Intravenous | Solco Healthcare US, LLC | ANDA | 43547-544 | 43547-0544-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Solco Healthcare US, LLC | ANDA | 43547-639 | 43547-0639-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .4 mg/2mL | InjectionIntramuscular, Intravenous | Solco Healthcare US, LLC | ANDA | 43547-640 | 43547-0640-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Par Health USA, LLC | ANDA | 49884-042 | 49884-0042-33 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Par Health USA, LLC | ANDA | 49884-065 | 49884-0065-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Par Health USA, LLC | ANDA | 49884-066 | 49884-0066-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | AvPAK | ANDA | 50268-363 | 50268-0363-15 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1425 | 51662-1425-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1431 | 51662-1431-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1484 | 51662-1484-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1487 | 51662-1487-0151662-1487-03 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1554 | 51662-1554-03 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | HF Acquisition Co LLC, DBA HealthFirst | ANDA | 51662-1601 | 51662-1601-0151662-1601-03 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Dr. Reddy's Laboratories Limited | ANDA | 55111-648 | 55111-0648-0155111-0648-05 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Dr. Reddy's Laboratories Limited | ANDA | 55111-649 | 55111-0649-0155111-0649-05 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | AuroMedics Pharma LLC | ANDA | 55150-292 | 55150-0292-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | AuroMedics Pharma LLC | ANDA | 55150-293 | 55150-0293-02 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | AuroMedics Pharma LLC | ANDA | 55150-294 | 55150-0294-05 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | AuroMedics Pharma LLC | ANDA | 55150-295 | 55150-0295-20 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Cardinal Health 107, LLC | ANDA | 55154-7475 | 55154-7475-05 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Aurobindo Pharma Limited | ANDA | 59651-435 | 59651-0435-47 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Golden State Medical Supply, Inc. | ANDA | 60429-666 | 60429-0666-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | American Health Packaging | ANDA | 60687-458 | 60687-0458-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Chartwell RX, LLC | ANDA | 62135-734 | 62135-0734-60 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Chartwell RX, LLC | ANDA | 62135-735 | 62135-0735-60 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/5mL | SolutionOral | Chartwell RX, LLC | ANDA | 62135-961 | 62135-0961-47 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | 62332-607 | 62332-0607-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | 62332-627 | 62332-0627-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | 62332-628 | 62332-0628-25 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | Alembic Pharmaceuticals Inc. | ANDA | 62332-629 | 62332-0629-10 | — |
|---|
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | Fresenius Kabi USA, LLC | ANDA | 63323-578 | 63323-0578-0163323-0578-0263323-0578-05 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Bryant Ranch Prepack | ANDA | 63629-2206 | 63629-2206-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 2 mg/1 | TabletOral | Bryant Ranch Prepack | ANDA | 63629-2207 | 63629-2207-01 | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Bryant Ranch Prepack | ANDA | 63629-7207 | 63629-7207-0163629-7207-0263629-7207-03+2 more | — |
|---|
| Glycopyrrolate | Glycopyrrolate 1 mg/1 | TabletOral | Bryant Ranch Prepack | ANDA | 63629-9287 | 63629-9287-01 | — |
|---|